The Evaluation of Patients with Severe COVID-19 Pneumonia Who are Recieving Favipiravir Treatment

Introduction: There is no known specific treatment for Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Our retrospective study evaluates the effectiveness of steroid treatment and the factors affecting treatment in patients with severe Coronavirus disease-2019 (COVID-19) pneumonia that...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Servet ÖZTÜRK, Onur ÇOLAK, Semra KAVAS, Derya ÖZTÜRK ENGİN, Serap DİKTAŞ TAHTASAKAL, Dilek ERDOĞAN ARI, Öznur DEMİROLUK, Berna ÖZDEMİR, Büşra Meral ÇETİNKAYA, Merve KAÇAR EKER, İrem Asena DOĞAN, Haluk VAHABOĞLU, Canan AĞALAR
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Infectious Diseases and Clinical Microbiology Specialty Society of Turkey 2021-12-01
Σειρά:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Θέματα:	covid-19 sars-cov-2 favipiravir steroid
Διαθέσιμο Online:	http://mjima.org/abstract.php?id=238
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!